{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:10:57Z","timestamp":1778004657323,"version":"3.51.4"},"reference-count":36,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["NCI R03 CA245979"],"award-info":[{"award-number":["NCI R03 CA245979"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["NCI U19 CA203654"],"award-info":[{"award-number":["NCI U19 CA203654"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,8,27]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Existing targeted lung cancer screening programmes are either annual or biennial. We tested the hypothesis that existing risk models can inform personalised screening intervals to improve cost-effectiveness and reduce interval cancers. Spirometric airflow obstruction is a biomarker of lung cancer risk available in some cohorts, so we also explored whether this could add predictive value for stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We tested the performance of risk models to predict next-round risk among baseline-negative participants in annual screening in Manchester and National Lung Screening Trial (NLST) cohorts. Models were adapted in the Eastern Cooperative Oncology Group and American College of Radiology Imaging Network (ECOG-ACRIN) sub-study of the NLST to investigate whether incorporating the spirometric percentage of predicted forced expiratory volume in 1\u2005second (FEV\n                      <jats:sub>1<\/jats:sub>\n                      % pred) improved discrimination and screening efficiency at next-round screens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In Manchester, where a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial model 2012 (PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      ) score of &gt;1.51% was used to determine eligibility, cancer was detected in 1.1% of those with a negative baseline scan after a 1-year interval (45 out of 4136), and in 2.5% of those with a risk of \u22656% (27 out of 1082). The same trend was seen in the NLST, but with lower risk overall. The PLCO\n                      <jats:sub>m2012<\/jats:sub>\n                      model discriminated next-round risk with an area under the curve (AUC) of 0.72 (95% CI 0.65\u20130.79), whereas the Lung Cancer Risk Assessment Tool + CT model for negative CT results (LCRAT+CT\n                      <jats:sub>neg<\/jats:sub>\n                      ) was potentially superior, with an AUC of 0.75 (95% CI 0.68\u20130.82) on external validation. The addition of FEV\n                      <jats:sub>1<\/jats:sub>\n                      % pred as a predictor variable modestly improved discrimination (\u0394AUC 0.01\u20130.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Baseline risk could be used to extend intervals for substantial numbers of lower-risk participants, thereby reducing cost and screening harms, while focusing resources on those at highest risk to avoid delayed detection. Adding FEV\n                      <jats:sub>1<\/jats:sub>\n                      % pred is unlikely to meaningfully contribute to next-round risk prediction.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00974-2025","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:05:23Z","timestamp":1760025923000},"page":"00974-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalised screening intensity based on existing lung cancer risk and spirometry"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5729-2548","authenticated-orcid":false,"given":"Patrick","family":"Goodley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Zahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-9376","authenticated-orcid":false,"given":"Haval","family":"Balata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sharman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kath","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4512-2899","authenticated-orcid":false,"given":"Richard","family":"Booton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-9960","authenticated-orcid":false,"given":"Matthew","family":"Sperrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary A.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.J.","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2026050510152137000_12.2.00974-2025.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"2026050510152137000_12.2.00974-2025.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2026050510152137000_12.2.00974-2025.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.05.044"},{"key":"2026050510152137000_12.2.00974-2025.4","first-page":"CD013829","article-title":"Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality","volume":"8","author":"Bonney","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026050510152137000_12.2.00974-2025.5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.21037\/tlcr.2018.05.12","article-title":"Lung cancer screening with low-dose CT: a world-wide view","volume":"7","author":"Pinsky","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2026050510152137000_12.2.00974-2025.6","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.21037\/tlcr-20-890","article-title":"Lung cancer screening in Europe: where are we in 2021?","volume":"10","author":"van Meerbeeck","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"2026050510152137000_12.2.00974-2025.7","unstructured":"Lung Cancer Policy Network . Interactive map of lung cancer screening (third edition). 2025. www.lungcancerpolicynetwork.com\/interactive-map\/"},{"key":"2026050510152137000_12.2.00974-2025.8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21037\/tlcr.2018.05.08","article-title":"Appropriate screening intervals in low-dose CT lung cancer screening","volume":"7","author":"Heuvelmans","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2026050510152137000_12.2.00974-2025.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00621-X"},{"key":"2026050510152137000_12.2.00974-2025.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70389-4"},{"key":"2026050510152137000_12.2.00974-2025.11","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00330-020-07275-w","article-title":"Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval","volume":"31","author":"Silva","year":"2021","journal-title":"Eur Radiol"},{"key":"2026050510152137000_12.2.00974-2025.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211776"},{"key":"2026050510152137000_12.2.00974-2025.13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215158"},{"key":"2026050510152137000_12.2.00974-2025.14","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211107"},{"key":"2026050510152137000_12.2.00974-2025.15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djz041","article-title":"Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result","volume":"111","author":"Robbins","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"2026050510152137000_12.2.00974-2025.16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.21037\/tlcr-20-1173","article-title":"Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)","volume":"10","author":"Gonzalez Maldonado","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"2026050510152137000_12.2.00974-2025.17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1164\/rccm.202005-1742LE","article-title":"Point-of-care spirometry identifies high-risk individuals excluded from lung cancer screening","volume":"202","author":"Lam","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050510152137000_12.2.00974-2025.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201410-1848OC"},{"key":"2026050510152137000_12.2.00974-2025.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.2467"},{"key":"2026050510152137000_12.2.00974-2025.20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq434"},{"key":"2026050510152137000_12.2.00974-2025.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0894OC"},{"key":"2026050510152137000_12.2.00974-2025.22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211377"},{"key":"2026050510152137000_12.2.00974-2025.23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/thorax-2023-220001","article-title":"Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation","volume":"79","author":"Goodley","year":"2023","journal-title":"Thorax"},{"key":"2026050510152137000_12.2.00974-2025.24","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-207168","article-title":"British Thoracic Society guidelines for the investigation and management of pulmonary nodules","volume":"70 Suppl 2","author":"Callister","year":"2015","journal-title":"Thorax"},{"key":"2026050510152137000_12.2.00974-2025.25","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213584"},{"key":"2026050510152137000_12.2.00974-2025.26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lungcan.2022.07.017","article-title":"Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK","volume":"171","author":"Robbins","year":"2022","journal-title":"Lung Cancer"},{"key":"2026050510152137000_12.2.00974-2025.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378"},{"key":"2026050510152137000_12.2.00974-2025.28","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report. 2024."},{"key":"2026050510152137000_12.2.00974-2025.29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1513\/AnnalsATS.201609-741OC","article-title":"Reduced expiratory flow rate among heavy smokers increases lung cancer risk. Results from the national lung screening trial\u2013American College of Radiology imaging network cohort","volume":"14","author":"Hopkins","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026050510152137000_12.2.00974-2025.30","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0183"},{"key":"2026050510152137000_12.2.00974-2025.31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.arbres.2025.03.022","article-title":"Feasibility of lung cancer screening in Europe: a pro\/con debate","volume":"61","author":"Ruano-Ravina","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"2026050510152137000_12.2.00974-2025.32","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/S1470-2045(18)30121-9","article-title":"Low-dose CT for lung cancer screening","volume":"19","author":"Ruano-Ravina","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026050510152137000_12.2.00974-2025.33","unstructured":"American College of Radiology Committee on Lung-RADS\u00ae . Lung-RADS\u00ae Version 1.1 Assessment Categories. Release date: 2019."},{"key":"2026050510152137000_12.2.00974-2025.34","unstructured":"NHS England \u2013 National Cancer Programme . Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography: Standard Protocol prepared for the Targeted Lung Health Checks Programme. 2022."},{"key":"2026050510152137000_12.2.00974-2025.35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00795-2022"},{"key":"2026050510152137000_12.2.00974-2025.36","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00203-2023"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00974-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:15:46Z","timestamp":1778001346000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00974-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1183\/23120541.00974-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00974-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}